Management of neovascular glaucoma with transscleral cyclophotocoagulation with diode laser alone versus combination transscleral cyclophotocoagulation with diode laser and intravitreal bevacizumab

Clinical and Experimental Ophthalmology

Volumn 39, Issue 4, 2011, Pages 318-323

  Fong, Anthony W ^a,b   Lee, Graham A ^a,b,c   O'Rourke, Peter ^d   Thomas, Ravi ^b,e  

^a City Eye Centre   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^d QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^e QUEENSLAND EYE INSTITUTE   (Australia)

Author keywords

Bevacizumab; Cyclodiode; Cyclophotocoagulation; Diode laser; Neovascular glaucoma

Indexed keywords

BEVACIZUMAB;

ADOLESCENT; ADULT; AGED; ANTERIOR EYE SEGMENT; ARTICLE; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DIODE LASER; EVISCERATION; FEMALE; HUMAN; INFORMATION PROCESSING; INTERMETHOD COMPARISON; INTRAOCULAR HYPOTENSION; INTRAOCULAR PRESSURE; LASER COAGULATION; MALE; NEOVASCULAR GLAUCOMA; NEOVASCULARIZATION (PATHOLOGY); SURGEON; TRANSSCLERAL CYCLOPHOTOCOAGULATION; VISUAL ACUITY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; ANTIBODIES, MONOCLONAL, HUMANIZED; CILIARY BODY; COMBINED MODALITY THERAPY; FEMALE; GLAUCOMA, NEOVASCULAR; HUMANS; INTRAOCULAR PRESSURE; INTRAVITREAL INJECTIONS; LASER COAGULATION; LASERS, SEMICONDUCTOR; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SCLERA; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY; YOUNG ADULT;

EID: 79958723105     PISSN: 14426404     EISSN: 14429071     Source Type: Journal    
DOI: 10.1111/j.1442-9071.2010.02449.x     Document Type: Article

References (18)

1. Kosoko O, Gaasterland DE, Pollack IP, Enger CL. Long-term outcome of initial ciliary ablation with contact diode laser transscleral cyclophotocoagulation for severe glaucoma. The Diode Laser Ciliary Ablation Study Group. Ophthalmology 1996; 103: 1294-302.
2. Yildirim N, Yalvac IS, Sahin A, Ozer A, Bosca T. A comparative study between diode laser cyclophotocoagulation and the Ahmed glaucoma valve implant in neovascular glaucoma - a long-term follow-up. J Glaucoma 2009; 18: 192-6.
3. Iliev ME, Gerber S. Long-term outcome of trans-scleral diode laser photocoagulation in refractory glaucoma. Br J Ophthalmol 2007; 91: 1631-5.
4. Threlkeld AB, Johnson MH. Contact transsceleral diode cyclophotocoagulation for refractory glaucoma. J Glaucoma 1999; 8: 3-7.
5. Wakabayashi T, Oshima Y, Sakaguchi H etal. Intravitreal bevacizumab to treat iris neovascularization and neovascular glaucoma secondary to ischaemic retinal diseases in 41 consecutive cases. Ophthalmology 2008; 115: 1571-80.
6. Ghosh S, Singh D, Ruddle JB, Shiu M, Coote MA, Crowston JG. Combined diode laser cyclocoagulation and intravitreal bevacizumab (Avastin) in neovascular glaucoma. Clin Experiment Ophthalmol 2010; 38: 353-7.
7. Gillies MC. Bevacizumab in ophthalmology: the controversy moves forward. Clin Experiment Ophthalmol 2010; 38: 333-4.
8. Jabs DA. Improving the reporting of clinical case series. Am J Ophthalmol 2005; 139: 900-5.
9. Sivak-Callcott JA, O'Day DM, Gass DM, Tsai JC. Evidence-based recommendations for the diagnosis and treatment of neovascular glaucoma. Ophthalmology 2001; 108: 1767-78.
10. Brooks A, Gillies WE. The development and mangement of neovascular glaucoma. Aust N Z J Ophthalmol 1990; 18: 179-85.
11. Ehlers JP, Spirn MJ, Lam A, Sivalingam A, Samuel MA, Tasman W. Combination intravitreal bevacizumab/panretinal photocoagulation versus panretinal photocoagulation alone in the treatment of neovascular glaucoma. Retina 2008; 28: 696-702.
12. Tsai JC, Feuer WJ, Parrish RK II, Grajewski AL. 5-Fluorouracil filtering surgery and neovascular glaucoma. Long-term follow-up of the original pilot study. Ophthalmology 1995; 102: 887-92.
13. Parrish R, Herschler J. Eyes with end-stage neovascular glaucoma: natural history following successful modified filtering operation. Arch Ophthalmol 1983; 101: 745-6.
14. Sisto D, Vetrugno M, Trabucco T, Cantatore F, Ruggeri G, Sborgia C. The role of antimetabolites in filtration surgery for neovascular glaucoma: intermediate-term follow-up. Acta Ophthalmol Scand 2007; 85: 267-71.
15. Yalvac IS, Eksioglu U, Satana B, Duman S. Long-term results of Ahmed glaucoma valve and Molteno implant in neovascular glaucoma. Eye 2007; 21: 65-70.
16. Sidoti PA, Dunphy TR, Baerveldt G etal. Experience with the Baerveldt glaucoma implant in treating neovascular glaucoma. Ophthalmology 1995; 102: 1107-18.
17. Miki A, Oshima Y, Otori Y, Kamei M, Tano Y. Efficacy of intravitreal bevacizumab as adjunctive treatment with pars plana vitrectomy, endolaser photocoagulation, and trabeculectomy for neovascular glaucoma. Br J Ophthalmol 2008; 92: 1431-3.
18. Beutel J, Peters S, Luke M, Aisenbrey S etal. Bevacizumab as adjuvant for neovascular glaucoma. Acta Ophthalmol 2010; 88: 103-9.